Company profile for Innovative Molecules

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Innovative Molecules is a start-up biotechnology company based within the New Jersey BioScience Center at North Brunswick (the NJEDA State Incubator). We are focused on the discovery and development of novel small molecule medicines for the treatment of cancer, metabolic-, and inflammatory-diseases, all areas with significant unmet medical need. Innovative Molecules is combining the power of established pharmacotherapeutic or ...
Innovative Molecules is a start-up biotechnology company based within the New Jersey BioScience Center at North Brunswick (the NJEDA State Incubator). We are focused on the discovery and development of novel small molecule medicines for the treatment of cancer, metabolic-, and inflammatory-diseases, all areas with significant unmet medical need. Innovative Molecules is combining the power of established pharmacotherapeutic or metabolic activity inherent to many natural or proven compounds with an innovative approach toward improving kinetic and efficacy parameters.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Dachauer Str. 65 80335, München​, Bayer
Telephone
Telephone
+1-732-253-7770
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-01-13/alfasigma-secures-exclusive-rights-from-innovative-molecules-to-parenteral-adibelivir-for-treatment-of-hsv-encephalitis-an-ultra-rare-disease

PHARMIWEB
13 Jan 2026

https://www.prnewswire.com/news-releases/innovative-molecules-completes-enrollment-of-phase-1b-clinical-trial-of-im-250-302482332.html

PR NEWSWIRE
16 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty